Research suggested the possibility that the enhancement of tripartite synaptic transmission associated with Cx43 induced by CLZ plays important roles in the mechanisms of clinical efficacy to treatment-resistant schizophrenia of CLZ. The gene discussed is GJA1; the disease is schizophrenia.